1. Home
  2. LNTH vs BXSL Comparison

LNTH vs BXSL Comparison

Compare LNTH & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$109.13

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Secured Lending Fund of Beneficial Interest

BXSL

Blackstone Secured Lending Fund of Beneficial Interest

HOLD

Current Price

$23.66

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNTH
BXSL
Founded
1956
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.5B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
LNTH
BXSL
Price
$109.13
$23.66
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$87.00
$27.18
AVG Volume (30 Days)
864.4K
1.8M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
12.87%
EPS Growth
N/A
N/A
EPS
1.80
0.11
Revenue
$343,374,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.19
N/A
P/E Ratio
$60.56
$217.09
Revenue Growth
3.62
N/A
52 Week Low
$47.27
$22.47
52 Week High
$111.86
$32.81

Technical Indicators

Market Signals
Indicator
LNTH
BXSL
Relative Strength Index (RSI) 66.22 48.00
Support Level $95.00 $23.26
Resistance Level N/A $24.99
Average True Range (ATR) 3.08 0.46
MACD -0.01 0.02
Stochastic Oscillator 71.02 29.33

Price Performance

Historical Comparison
LNTH
BXSL

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.

Share on Social Networks: